{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:58:42Z","timestamp":1648713522960},"reference-count":8,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.oftal.2016.06.005","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T09:47:33Z","timestamp":1471340853000},"page":"559-560","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropat\u00eda \u00f3ptica hereditaria de Leber: \u00bfde qu\u00e9 perspectivas terap\u00e9uticas disponemos?"],"prefix":"10.1016","volume":"91","author":[{"given":"L.","family":"Castillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Arruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2016.06.005_bib0005","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber's hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.oftal.2016.06.005_bib0010","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.oftal.2016.06.005_bib0015","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1093\/brain\/aws279","article-title":"Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy","volume":"136","author":"Klopstock","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.oftal.2016.06.005_bib0020","unstructured":"European Medicines Agency. 25 june 2015 EMA\/480039\/2015 Committee for Medicinal Products for Human Use (CHMP). Assessment report. Raxone. International non-proprietary name: idebenone. Procedure No. EMEA\/H\/C\/003834\/0000."},{"key":"10.1016\/j.oftal.2016.06.005_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.oftal.2016.06.005_bib0030","first-page":"6921","article-title":"Targeting estrogen receptor \u03b2 as preventive therapeutic strategy for Leber's hereditary optic neuropathy","volume":"24","author":"Pisano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.oftal.2016.06.005_bib0035","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): US National Library of Medicine [citado el 15 Junio 2016]. Disponible en: http:\/\/www.clinicaltrials.gov"},{"key":"10.1016\/j.oftal.2016.06.005_bib0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: Initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669116301241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669116301241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T01:55:39Z","timestamp":1536458139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669116301241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0365669116301241"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2016.06.005","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropat\u00eda \u00f3ptica hereditaria de Leber: \u00bfde qu\u00e9 perspectivas terap\u00e9uticas disponemos?","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2016.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}